The Patent Finder

14NER Oncology, Inc.

Also on record
Records under this name other than the patents 14NER Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 2 of 2 · Back to 14NER Oncology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,518,130Use of ERBB3 Inhibitors in the Treatment of Triple Negative and Basal-Like Breast Cancers
Lapsed on the fee record
Ended Dec 13, 2024 · High confidence
Lapsed on the fee recordEnded Dec 13, 2024High confidence
US 8,895,001Use of ERBB3 Inhibitors in the Treatment of Triple Negative and Basal-Like Breast Cancers
Lapsed on the fee record
Ended Nov 25, 2022 · High confidence
Lapsed on the fee recordEnded Nov 25, 2022High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited